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Objectives: To compare percutaneous transluminal ngioplsty (PTA) against exercise training in the treatment ofstable 
claudication. 
Design: Prospective, randomised trial.' 
Materials: Fifty-six patients with unilateral, stable, lower limb claudication assessed prior to randomisation, at 3 monthly 
intervals for 15 months, and at approximately 6 years follow-up. Thirty-seven patients were available for long term 
review. 
Outcome measures: Ankle/brachial pressure index (ABPI), treadmill claudication and maximum walking distances, 
percentage fail in ankle systolic pressure after exercise. 
Results: Significant increases were seen in ABPI in the patients treated with PTA at all assessment to 15 months. However 
in terms of improved walking performance, the most significant changes in claudication and maximum walking distance 
were seen in the exercise training group. At long term follow-up, there was no significant difference between the groups. 
Subgroup analysis by angiographic site of disease showed greater functional improvement i  those patients with disease 
confined to the superficial femoral artery treated by exercise training. The overall prognosis for the whole group of patients 
was benign, with only two (4%) undergoing amputation. 
Conclusions: Exercise training confers agreater improvement i  claudication and maximum walking distance than PTA, 
especially in patients with disease confined to the superficial femoral artery. 
Key Words: Intermittent claudication; Percutaneous transluminal ngioplasty; Exercise therapy; Randomised controlled 
trial. 
Introduction 
Percutaneous transluminal angioplasty (PTA) is an 
established treatment option for patients with lower 
limb intermittent claudication. It has low complication 
rates I and 5 year patency rates of 80% for aortoiliac 
and 60% for femoropopliteal disease. 1 Exercise ther- 
apy is an alternative, non-invasive treatment for 
claudication that has been shown to improve patients' 
walking performance, 2~ but its effectiveness com- 
pared to PTA has not been fully established. A 
randomised, prospective trial was established to com- 
pare these two treatment options, and preliminary 
results showed a greater improvement in the medium 
term following exercise therapy than after PTA. 5 This 
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paper reports the final results of the study, including 
the long-term follow-up of patients 5 years after 
randomisation. 
Patients and Methods 
Between July 1987 and September 1990, 56 patients 
with stable unilateral claudication were randomised to 
receive either PTA (30 patients) or to enter a super- 
vised exercise programme (26 patients). The entry 
criteria for the trial were as follows: (1) stable 
unilateral claudication with a failure of conservative 
management for 3 months prior to randomisation; (2) 
a lesion(s) on angiography suitable for angioplast~ as 
agreed by surgeons and radiologists; (3) a maximum 
walking distance of less than 375 m, to allow patients 
to double their treadmill maximum walking distance 
within the study protocol. Patients were assessed prior 
to randomisation, at 3 monthly intervals for 15 
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Table 1. Angiographic site of lesion(s) in each group 
Site of Lesion PTA (n=30) Exercise (n=26) 
Superficial Femoral Artery (SFA) 15 13 
Iliac Artery/Iliac and Superficial 
Femoral Artery (IA) 15 13 
months, and finally at almost 6 years after treatment. 
At each assessment, resting ankle/brachial pressure 
indices (ABPI) were measured and the patients exer- 
cised on a treadmill at 3 km/h up a 10 degree incline. 
Claudication and maximum walking distances were 
recorded up to a maximum of 750 m (equivalent to 15 
min walking). Within 45 s of stopping exercise, the 
ankle systolic pressure was re measured and 
expressed as a percentage of the resting ankle systolic 
pressure (% fall in ankle pressure). 
In May and June 1994 those patients who were still 
available for review were re-evaluated to assess their 
long-term progress. Thirty-seven patients (22 PTA; 15 
Exercise) were re-tested, 10 patients had died (4 PTA; 
6 Exercise) and the remaining patients were either 
uncontactable, too ill for review or had undergone 
amputation. Excluding patients who had died, 80% of 
patients who were available were re-evaluated. 
Subgroups of patients divided according to the 
angiographic site of disease are shown in Table 1. Half 
of the patients in each treatment group had disease 
confined to the superficial femoral artery, and in other 
half a proximal iliac artery lesion was present. The 
number of patent run-off vessels below the knee did 
not differ significantly between groups. 
PTA was performed using a conventional guide- 
wire and balloon catheter technique. The lumen was 
overdilated by 10% above normal, and the balloon 
inflated for two periods of 45 seconds using the 
manufacturer's recommended inflation pressures. 
Heparin cover of 3000-5000 units was given intra- 
arterially during the procedure. Post-procedure angio- 
grams were taken to confirm the success of the 
angioplasty. 
Patients randomised to the exercise training group 
were invited to attend supervised exercise classes 
twice a week for the first 6 months. After this, 
attendance was required on a regular basis according 
to the patient's progress. Each class lasted 30 min. 
Dynamic leg exercises were performed, with the 
intensity of exercise increasing as the patient's exercise 
tolerance improved. Patients were also encouraged to 
perform the same exercises at home on a regular 
basis. 
Statistical analysis 
Comparison of proportions between groups was made 
using either the Chi-square test with Yates correction 
or Fisher's exact probability test as appropriate. The 
non-parametric data of claudication distance, max- 
imum walking distance and % fall in ankle pressure 
were analysed as paired data sets with the pre- 
treatment values using the Wilcoxon matched pairs 
signed rank sum test (Wilcoxon paired test). 
Results 
Mean age and proportions of male to female were not 
significantly different between groups for the patients 
reviewed. The follow-up time for the PTA group was 
median 74 months (range 48-83) and for the exercise 
group was median 70 months (range 45-83). Pre- 
treatment values for ABPI, claudication distance, 
maximum walking distance and % fall in ankle 
pressure were similar for both groups. 
In the intervening time since randomisation four 
patients in the PTA group and 4 patients in the 
exercise group had undergone angioplasty of the 
ipsilateral leg. Of the PTA patients undergoing repeat 
ipsilateral angioplasty, three had the original disease 
site re-angioplastied, and one patient had a further 
angioplasty in a different arterial segment. In the 
contralateral leg, three PTA patients and three exercise 
patients had received further angioplasty. Two 
patients had undergone reconstructive surgery; one in 
the PTA group had an aortobifemoral graft, and one in 
the exercise group had a femoro-femoral cross-over 
graft donating to the ipsilateral eg. Overall in the 
entire randomised group of 56 patients, only two (4%) 
had undergone amputation. 
The profile of the changes of ABPI, maximum 
walking distance and % fall in ankle pressure with 
time are shown in Figs. 1-3. In the interests of clarity, 
the data at long term follow-up have been presented at 
the median follow-up time of 70 months, although it 
should be stressed that the range of long term follow- 
up lies between 45 and 83 months. Claudication 
distance was significantly greater than pre-treatment 
values in the exercise group at 6 months (p = 0.005), 9 
months (p=0.001), 12 months (p=0.001) and 15 
months (p = 0.0001) in contrast to the PTA group 
which showed no significant improvement at any of 
these time intervals. 
Patients' performance was analysed further by 
subgroups according to the different patterns of 
disease, as shown in Table 1. The improvement in 
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Fig. 1. Median ABPI vs.  time (standard error bars). *p = 0.0001, 
fp = 0.001, ~cp = 0.005, §p = 0.02 (Wilcoxon paired test). (O) PTA; (©) 
exercise. 
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Fig. 3. Median maximum walking distance vs .  time (standard error 
bars). *p < 0.005, tp < 0.001, :~p = 0.0001 (Wilcoxon paired test). (0) 
PTA; (©) exercise. 
walking ability in patients with a proximal iliac artery 
lesion (IA) was compared with that of patients who 
had disease confined to the superficial femoral artery 
only (SFA). The changes in claudication distance and 
maximum walking distance for patients with IA or 
SFA disease are shown in Figs. 4 and 5. Significant 
increases in ABPI were seen only in the group 
receiving PTA, regardless of the site of disease. The 
ABPI showed an increase at 3 (p = 0.002), 6 (p = 0.01), 9 
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Fig. 2. Median % fall in ankle pressure vs.  time (standard error bars). 
*p = 0.01, -[p = 0.005, :~p = 0.02 (Wilcoxon paired test). (@) PTA; (©) 
exercise. 
(p = 0.01), and 15 (p = 0.04) months for the SFA group 
treated with angioplast:~ and at 3 (p=0.03), 6 
(p = 0.003) and 9 (p = 0.02) months for the IA group. In 
contrast, none of the exercise training patients (both 
IA and SFA) had any significant increase in ABPI 
during this same time. 
At long term follow-up, only two patients admitted 
to continuing to perform the exercises every day, and 
a further three patients exercised more than twice in 
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Fig. 4. Median claudication distance vs.  time (standard error bars). 
Subgroup analysis according to site of disease (IA or SFA). *p = 0.01, 
tp = 0.009, :~p = 0.008 (Wilcoxon paired test). (0)  SFA PTA; (©) SFA 
exercise; ( . )  IA PTA; ([~) IA exercise. 
Eur J Vasc Endovasc Surg Vol 11, May 1996 
412 J .M .T .  Perk ins  et al. 
900 
800 
700 
600 
500 
400 
~ 300 
N 2OO j f f  
/ / / / 
100~- _ ~ ' " - -  ~-, z _ [_ 
I I I I I 
0 3 6 9 12 15 
Months 
Fig. 5. Median maximum walking distance vs. time (standard error 
bars). Subgroup analysis according tosite of disease (IA or SFA). 
*p = 0.02, tp = 0.004, {p = 0.003, §p = 0.005, ] 1; p = 0.001 (Wilcoxon 
paired test). (O) SFA PTA; (©) SFA exercise; (ll) IA PTA; ([Z) IA 
exercise. 
each week. The remainder exercised only sporadically. 
Nine of the 22 patients (41%) reviewed in the PTA 
group and 8 out of 15 (53%) in the exercise group 
continued to smoke. 
Discuss ion  
Over the past decade percutaneous transluminal 
angioplasty (PTA) has been increasingly used as the 
first-line treatment for lower limb ischaemia, either 
alone or in conjunction with reconstructive surgery. 6 
This preference for the use of PTA over the more 
conservative management of exercise training appears 
to have arisen from an unproven perception that PTA 
produced a better outcome for patients. This pro- 
spective, randomised study clearly shows that the 
increases in claudication distance and maximum 
walking distance xperienced by patients enrolled into 
an exercise programme were significantly greater than 
those in patients undergoing PTA. These increases in 
both claudication distance and maximum walking 
distance in those randomised to the exercise pro- 
gramme are in line with those in non-randomised 
observational studies on exercise training. 2'3 
The beneficial effects of exercise training are not 
simply produced by an increase in collateral blood 
flow. The studies of Larsen and Lassen 2and Ekroth et 
al. s showed no increase in limb blood flow as 
measured by Xenon-133 clearance studies 2 or strain 
gauge plethysmography, 3 observations that are sup- 
ported by the lack of increase in ABPI seen in the 
exercise group in our study. At a cellular level, exercise 
promotes changes in the enzymatic activity, 7'8 and the 
size and numbers of mitochondria within the muscle, 9 
this allowing more efficient utilisation of oxygen. 
Substrate xtraction from blood is enhanced. 1° Within 
muscle, there is a change of fibre type, with an increase 
in Type 1 fibres, 11 which are characterised by a more 
dense capillary network, thus allowing more efficient 
delivery of substrate to the muscle. Blood fluidity, 
characterised by an increase in red cell deformity and 
a reduction in blood viscosit)512 is increased by 
exercise training. 
Previous studies have suggested that the beneficial 
effects of exercise training are seen regardless of the 
site of disease. 3 The subgroup analysis of the patients 
in this study according to the site of the lesion, does 
not support his view, although the numbers in each 
group are small. The most significant improvement 
was seen in patients with disease confined to the 
superficial femoral artery. Disease in this arterial 
segment is often multifocal, and the results of angio- 
plasty within the femoropopliteal segment are less 
convincing. The relatively small number of patients in 
each subgroup prevent absolutely definitive conclu- 
sions from being reached, but would support recom- 
mending exercise training as the initial management 
of choice in stable claudicants with lesions in the SFA 
only. This is an area for further investigation. 
In the long-term the functional outcome between 
the two groups was identical. The results show a 
small but non-significant increase in all parameters in 
both groups compared to pre-treatment values, with 
an encouragingly benign long-term progress regard- 
less of treatment option. The amputation rate for the 
entire randomised group of patients and the rate of 
surgical intervention are similar to those reported in 
studies of the natural history of intermittent claudica- 
tion. 13-15 The benign natural history of intermittent 
claudication is confirmed by our study irrespective of 
whether the treatment given initially was PTA or 
exercise therapy. 
In conclusion, we suggest that many patients 
currently treated with PTA would be suitable for, and 
benefit from exercise training. Although the complica- 
tion rate of PTA is low, nonetheless a small percentage 
(2%) of patients will require surgery to correct 
complications. 16 There are no complications of exer- 
cise training, nor does it compromise subsequent PTA 
or surgery should they be necessary. Exercise training 
has the additional merit of promoting a generalised 
feeling of well-being. 2 Some patients with coexisting 
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cardiac or arthritic conditions may be prevented from 
exercising, and some younger patients who are still in 
full employment may find the exercise programme 
excessively time-consuming, but these are small sub- 
groups and the majority of patients with stable 
intermittent claudication would gain a significant 
improvement in walking performance from enrolment 
into an exercise programme. The use of exercise 
training as an adjunctive treatment following recon- 
structive surgery has been shown to improve the 
benefit conferred by such surgery 17 and it is possible 
that the combination of PTA and exercise training may 
confer the maximal advantage to the patient. This 
requires further investigation. Long-term fears for the 
viability of limbs in patients treated with exercise 
training are not justified. Although the benefits of 
exercise therapy are not sustained in the long term, 
because patients tend to stop exercising as time goes 
by, the long term outcome is identical to patients who 
receive treatment with PTA. 
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